Literature DB >> 12235544

[Clinical symptoms in 35 children and adolescents with craniopharyngeoma at the time of diagnosis].

T Rohrer1, K Gassmann, M Buchfelder, D Wenzel, R Fahlbusch, H G Dörr.   

Abstract

AIM: Hormonal deficiencies, visual disturbances, or cerebral symptoms are often the symptoms through which craniopharyngiomas (CP) first become clinically manifest. As these symptoms can exist for a long period of time various specialists are often consulted before the final diagnosis is made. PATIENTS AND METHODS: Between the years 1970 and 1998, 37 children and adolescents with CP were treated in Erlangen. The documents of 35 patients (22 male, 13 female) were evaluated retrospectively.
RESULTS: The median age of the children at diagnosis was 9,3 years (1,3 - 15,6 years). The most frequently documented symptoms were: headache 57 % (median duration 7 months; varying from 1 week to 6 years), visual disturbances 45 % (median duration 2 months, range 2 weeks to 10 years), and reduced growth 40 % (median duration 1 year, range 3 months to 5 years). On average the reported symptoms were present for 15 months (median 5 months, time span 1 week to 10 years).
CONCLUSION: The clinical symptoms of CP are non-specific and highly varied. Endocrine disturbances are the primary objective finding. Correct interpretation of the symptoms are required for the early diagnosis of CP.

Entities:  

Mesh:

Year:  2002        PMID: 12235544     DOI: 10.1055/s-2002-33983

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  3 in total

1.  [Endonasal removal of a large recurrent craniopharyngioma using intraoperative navigation].

Authors:  J Wurm; K Bumm; H Steinhart; R Fahlbusch; H Iro
Journal:  HNO       Date:  2005-11       Impact factor: 1.284

2.  Craniopharyngiomas presenting as incidentalomas: results of KRANIOPHARYNGEOM 2007.

Authors:  Svenja Boekhoff; Brigitte Bison; Maria Eveslage; Panjarat Sowithayasakul; Hermann L Müller
Journal:  Pituitary       Date:  2019-10       Impact factor: 4.107

3.  [Hypopituitarism].

Authors:  F Hammer; W Arlt
Journal:  Internist (Berl)       Date:  2004-07       Impact factor: 0.743

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.